GAGNON ROBERT E. (Chief Financial Officer) sold 2.5% of their position (14K shares) of OPUS GENETICS, INC. on the open market
Open‑market sale worth $49.6K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 10/27/2026ACC: 0001140361-26-040896
Officer· Chief Financial Officer
Since Sep 2025
-14K
Net shares
Net seller
$49.6K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
14K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−14K
Price / share
$3.55
Trade value
$49.65K
% of position
2.5%
10/23/2026
556.38K→542.38K
Total
Net shares
−14K
Net value
-$49.65K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/23/2026 | S · Sale | −14K | $3.55 | $49.65K | 2.5% | 556.38K | 542.38K |
| Total | −14K | -$49.65K | ||||||
Derivative Transactions0
No derivative transactions reported